JONATHAN NIKUTTA: Open Payments
NPI 1972228724 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 33 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $120 |
| PFIZER INC. | 4 | $110 |
| Lilly USA, LLC | 3 | $93 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Dexcom, Inc. | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Corcept Therapeutics | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Amgen Inc. | 2 | $29 |
Products named: JARDIANCE, GEMTESA, PREVNAR 20, TRELEGY ELLIPTA, Dexcom G6 Transmitter, Kerendia, Korlym, OTEZLA.
Industry payments across MI — which companies pay providers there.
